Ryman's rising debt the topic du jour

Ryman's rising debt the topic du jour
Ryman chief executive Gordon MacLeod is a "rockstar" CEO, according to analyst Stephen Ridgewell.
Jenny Ruth
Ryman Healthcare prides itself on never having had to ask shareholders for more capital since its $25 million float in 1999.That's because it has a long track record of recycling capital from building and then selling down its retirement villages.It's clear the company is loath to change that status, despite gearing having reached 44%, squarely in the post-GFC category of 'too high'.Investors and analysts have been eyeing its rising debt for several years now and at least one broking firm, Jarden, is suggesting Ryman would benef...

More Opinion

Light at the end of Holidays Act reform tunnel
Law & Regulation

Bronwyn Heenan: Light at the end of Holidays Act reform tunnel

We are finally going to see the proposal for sensible changes to holiday legislation.

Finally, a small stand is made against Big Tech
Opinion

Peter Griffin: Finally, a small stand is made against Big Tech

However, we look set to repeat the errors of the Web 2.0 era.

Peter Griffin 04 Jul 2024
Benchmark-beaters: how ESG gives indexers active power
Opinion

David Chaplin: Benchmark-beaters: how ESG gives indexers active power

The ESG push among institutional investors is changing the mix.

David Chaplin 03 Jul 2024
Has ArborGen finally crossed the Rubicon?
Opinion

Paul McBeth: Has ArborGen finally crossed the Rubicon?

Long-suffering shareholders might be dubious about the emerging green shoots.

Paul McBeth 02 Jul 2024